Important Drug Discovery Chemistry Update


In light of evolving updates and concerns around the coronavirus, we’ve decided to reschedule Drug Discovery Chemistry to August 24-28, 2020. These new dates provide us the opportunity to deliver the quality event that you expect from CHI, and a safe environment for our attendees, speakers, sponsors, exhibitors, and staff. Over the coming days, we will be working with all our stakeholders to ensure continuity for the event and will share more information with you as it becomes available.


COVID-19 Updates & FAQ


Medicinal Chemistry: Where Are We Headed?

Wendy Young, PhD
Senior Vice President, Small Molecule Discovery, Genentech

Translational Chemistry

Phil Baran, PhD
Professor, Department of Chemistry, Scripps Research

About the Event

Cambridge Healthtech Institute's 15th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent conferences. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery, plus even more short courses to choose from.



Maximize your educational and networking opportunities while in San Diego by adding on one or more interactive short courses! Covering some of the hottest topics in the field, these short courses are taught by leading researchers from industry and academia. Topics include the ubiquitin-proteasome system, immunology, pharmacology, FBDD, macrocyclics, phenotypic screening, PROTACs, GPCR structures, physical properties of drugs, DNA-encoded libraries, immuno-oncology, ligand-receptor interactions, and drug metabolism.